-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Need To Know: Analysts Just Made A Substantial Cut To Their IMAX China Holding, Inc. (HKG:1970) Estimates
Need To Know: Analysts Just Made A Substantial Cut To Their IMAX China Holding, Inc. (HKG:1970) Estimates
One thing we could say about the analysts on IMAX China Holding, Inc. (HKG:1970) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. Both revenue and earnings per share (EPS) forecasts went under the knife, suggesting analysts have soured majorly on the business.
Following the latest downgrade, the two analysts covering IMAX China Holding provided consensus estimates of US$91m revenue in 2022, which would reflect a considerable 19% decline on its sales over the past 12 months. Statutory earnings per share are anticipated to plummet 38% to US$0.07 in the same period. Prior to this update, the analysts had been forecasting revenues of US$107m and earnings per share (EPS) of US$0.09 in 2022. Indeed, we can see that the analysts are a lot more bearish about IMAX China Holding's prospects, administering a substantial drop in revenue estimates and slashing their EPS estimates to boot.
Check out our latest analysis for IMAX China Holding
SEHK:1970 Earnings and Revenue Growth July 15th 2022The consensus price target fell 10% to US$1.38, with the weaker earnings outlook clearly leading analyst valuation estimates. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic IMAX China Holding analyst has a price target of US$11.60 per share, while the most pessimistic values it at US$10.00. As you can see the range of estimates is wide, with the lowest valuation coming in at less than half the most bullish estimate, suggesting there are some strongly diverging views on how think this business will perform. As a result it might not be possible to derive much meaning from the consensus price target, which is after all just an average of this wide range of estimates.
Of course, another way to look at these forecasts is to place them into context against the industry itself. Over the past five years, revenues have declined around 7.9% annually. Worse, forecasts are essentially predicting the decline to accelerate, with the estimate for an annualised 19% decline in revenue until the end of 2022. Compare this against analyst estimates for companies in the broader industry, which suggest that revenues (in aggregate) are expected to grow 16% annually. So while a broad number of companies are forecast to grow, unfortunately IMAX China Holding is expected to see its sales affected worse than other companies in the industry.
The Bottom Line
The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for IMAX China Holding. Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that IMAX China Holding's revenues are expected to grow slower than the wider market. After such a stark change in sentiment from analysts, we'd understand if readers now felt a bit wary of IMAX China Holding.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At least one analyst has provided forecasts out to 2024, which can be seen for free on our platform here.
Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
关于分析师们,我们可以说一件事IMAX中国控股有限公司(HKG:1970)-他们并不乐观,刚刚对该组织的近期(法定)预测做出了重大负面修订。营收和每股收益(EPS)预期都遭到了下调,这表明分析师对这项业务的态度已经恶化到了极点。
在最近一次下调评级后,负责IMAX China Holding的两位分析师提供了2022年营收9100万美元的共识估计,这将反映出该公司在过去12个月的销售额大幅下降19%。预计同期法定每股收益将暴跌38%,至0.07美元。在此次更新之前,分析师一直预测2022年营收为1.07亿美元,每股收益(EPS)为0.09美元。事实上,我们可以看到,分析师们对IMAX China Holding的前景更加悲观,大幅下调了收入预期,并大幅下调了每股收益预期。
查看我们对IMAX中国控股的最新分析
联交所:1970年盈利及收入增长2022年7月15日共识目标价下跌10%,至1.38美元,较弱的盈利前景显然领先于分析师的估值预期。然而,盯着一个单一的价格目标可能是不明智的,因为共识目标实际上是分析师价格目标的平均值。因此,一些投资者喜欢看看预估区间,看看对该公司的估值是否存在分歧意见。最乐观的IMAX China Holding分析师的目标价为每股11.60美元,而最悲观的分析师则认为目标价为10.00美元。正如你可以看到的,估计的范围很大,最低的估值不到最乐观估计的一半,这表明对于这项业务将如何表现,存在一些强烈的分歧。因此,可能不可能从共识价格目标中获得太大意义,毕竟这只是这一广泛估计范围的平均值。
当然,看待这些预测的另一种方式是将它们放在与行业本身相反的背景下。在过去的五年里,收入每年下降约7.9%。更糟糕的是,预测基本上是在预测下降速度将加快,预计到2022年底,收入按年率计算将下降19%。相比之下,分析师对更广泛行业的公司的预测显示,(总体)收入预计将以每年16%的速度增长。因此,尽管预计将有大量公司增长,但不幸的是,IMAX China Holding的销售受到的影响预计将比业内其他公司更严重。
底线
新的预估中最大的问题是,分析师下调了对IMAX China Holding的每股收益预估,这表明IMAX China Holding将面临业务逆风。不幸的是,分析师也下调了他们的营收预期,行业数据显示,IMAX China Holding的营收增速预计将低于大盘。在分析师的情绪发生如此明显的变化后,如果读者现在对IMAX China Holding感到有点警惕,我们会理解的。
话虽如此,该公司盈利的长期轨迹比明年重要得多。至少有一位分析师提供了对2024年的预测,这可以在我们的平台上免费看到。
当然,看到公司管理层投资大笔资金投资一只股票,就像知道分析师是否在下调他们的预期一样有用。所以你可能也想搜索一下这个免费内部人士正在买入的股票清单。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧